Oncology and hematology

First, the compatibility of HLA tissues for the transplanted bone marrow must be ensured. Perfect patient-donor compatibility and tissue group incompatibility with a maximum number of one acceptable for bone marrow transplantation. Recently, it has become possible to perform transplant operations with more than 50% compliance between the kin donor and the patient, if there is no kin donor or extra-kin to the high-risk patient.

If the marrow does not start producing blood cells within 15 days, rejection of the donor’s bone marrow by the recipient is dangerous. This rate ranges from 5% to 12% in allogeneic transplants depending on the type of donor and the degree of compatibility. This problem is almost non-existent in self-cultivation operations.

Disease recurrence after transplantation is a possible outcome. These possibilities vary depending on the underlying disease.